BridgeBio Oncology Therapeutics Inc.
BBOT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,698 | $0 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $252 | $0 | $0 | $0 |
| Total Curr. Assets | $1,950 | $0 | $0 | $0 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $192,449 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $25 | $333 | $145 | $144 |
| Total NC Assets | $192,474 | $333 | $145 | $144 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $194,424 | $333 | $145 | $144 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $0 | $70 | $43 | $37 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $188 | $326 | $123 | $126 |
| Total Curr. Liab. | $188 | $396 | $166 | $163 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $5,520 | $0 | $0 | $0 |
| Total NC Liab. | $5,520 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $5,708 | $396 | $166 | $163 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $192,450 | $0 | $0 | $0 |
| Retained Earnings | -$3,733 | -$89 | -$47 | -$43 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $25 | $25 | $25 |
| Total Equity | $188,717 | -$64 | -$22 | -$18 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $194,424 | $333 | $145 | $144 |
| Net Debt | -$1,698 | $70 | $43 | $37 |